CLOV vs MYGN · rev $1.37B vs rev $837.6M
Clover Health Investments Corp (CLOV) versus Myriad Genetics Inc (MYGN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MYGN revenue for 2024-12-31 was $837.6M. Net income was -$127.3M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. MYGN currently screens at market cap $413.7M.
CLOV currently screens at market cap $1.55B. MYGN currently screens at market cap $413.7M.
Not investment advice. Open the CLOV and MYGN stock pages for the full models.
Not investment advice.